The Human Extracellular Matrix Diseasome Reveals Genotype-Phenotype Associations with Clinical Implications for Age-Related Diseases

Thumbnail Image

Files

preprints202303.0192.v1.pdf (1.96 MB)
preprints202303.0192.v1.zip (13.62 MB)

Links to Files

https://www.preprints.org/manuscript/202303.0192/v1

Permanent Link

https://doi.org/10.20944/preprints202303.0192.v1
 http://hdl.handle.net/11603/27423

Collections

UMBC Biological Sciences Department
UMBC Faculty Collection
UMBC Student Collection

Author/Creator

Author/Creator ORCID

Date

2023-03-10

Type of Work

journal articles
preprints
Text

Department

Program

Citation of Original Publication

Rights

This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution 4.0 International (CC BY 4.0)

Subjects

Abstract

The extracellular matrix (ECM) is earning an increasingly relevant role in many disease states and the process of aging. Analyzing these disease states is possible with GWAS and PheWAS methodology, and through our analysis, we aimed to explore the relationships between polymorphisms in the compendium of ECM genes (i.e., matrisome genes) in various disease states. A significant contribution on the part of the ECM polymorphisms is evident in many varying types of diseases, particularly those in the core matrisome genes. Our results confirm previous links to connective tissue disorders, but also unearth new and underexplored relationships with neurological, psychiatric, and age-related disease states. Upon analysis of drug indications for gene-disease relationships, we identified numerous targets that may be repurposed for age-related pathology. The identification of ECM polymorphisms and their contribution to disease plays an integral role in future therapeutic developments, drug repurposing, precision medicine, and personalized care.